BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36480802)

  • 21. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
    Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
    J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C.
    Meyerson BE; Agley JD; Jayawardene W; Eldridge LA; Arora P; Smith C; Vadiei N; Kennedy A; Moehling T;
    Res Social Adm Pharm; 2020 May; 16(5):699-709. PubMed ID: 31611071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level.
    Seña AC; Willis SJ; Hilton A; Anderson A; Wohl DA; Hurt CB; Muir AJ
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):57-64. PubMed ID: 27168663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement.
    Cook C; Reid L; Elsharkawy AM; Radley A; Smith S; McPherson S; Crockford D; Dillon JF; Wright M; Morris D; Malik H; Keall S; Powell J; Catt J; Hampton H; Boothman H; Shah S; Spear J; Ustianoski A; John P; Stevens H; Khakoo SI; Parkes J; Buchanan RM
    Public Health; 2024 Jul; 232():153-160. PubMed ID: 38781782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a pharmacy-based blood lead testing program: A retrospective analysis.
    McMahon B; Fouts M; Klepser D; Klepser M
    J Am Pharm Assoc (2003); 2023; 63(5):1628-1633. PubMed ID: 37169255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and Acceptability of Oral HIV Self-Testing among Community Pharmacy Clients in Kenya: A Feasibility Study.
    Mugo PM; Micheni M; Shangala J; Hussein MH; Graham SM; Rinke de Wit TF; Sanders EJ
    PLoS One; 2017; 12(1):e0170868. PubMed ID: 28125699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a Collaborative HIV and Hepatitis C Screening Program in Appalachian Urgent Care Settings.
    Burrell CN; Sharon MJ; Davis SM; Wojcik EM; Martin IBK
    West J Emerg Med; 2018 Nov; 19(6):1057-1064. PubMed ID: 30429942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine screening for hepatitis C viral infection in patients undergoing elective cranial neurosurgery.
    Nussbaum ES; Kallmes K; Lowary J; Nussbaum LA
    J Neurosurg; 2018 Sep; 131(3):941-948. PubMed ID: 30215562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV and Hepatitis C Virus Screening Practices in a Geographically Diverse Sample of American Community Health Centers.
    Mayer KH; Crawford P; Dant L; Gillespie S; Singal R; Vandermeer M; Muench J; Long T; Quach T; Chaudhry A; Crane HM; Lembo D; Mills R; McBurnie MA
    AIDS Patient Care STDS; 2016 Jun; 30(6):237-46. PubMed ID: 27286294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-Routine HCV/HIV Testing: Seroprevalence and Linkage to Care in Four Community Health Centers in Philadelphia, Pennsylvania.
    Coyle C; Kwakwa H
    Public Health Rep; 2016; 131 Suppl 1(Suppl 1):41-52. PubMed ID: 26862229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effective.
    Buchanan R; Cooper K; Grellier L; Khakoo SI; Parkes J
    J Viral Hepat; 2020 Jan; 27(1):36-44. PubMed ID: 31520434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV and HBV testing acceptability and knowledge among urban emergency department patients and pharmacy clients.
    Calderon Y; Cowan E; Schramm C; Stern S; Brusalis C; Iscoe M; Rahman S; Verma R; Leider J
    Prev Med; 2014 Apr; 61():29-33. PubMed ID: 24382298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missed opportunities for HIV screening in pharmacies and retail clinics.
    Dugdale C; Zaller N; Bratberg J; Berk W; Flanigan T
    J Manag Care Spec Pharm; 2014 Apr; 20(4):339-45. PubMed ID: 24684638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community.
    Amesty S; Crawford ND; Nandi V; Perez-Figueroa R; Rivera A; Sutton M; Weidle PJ; Willis L; Smith DK; Hernandez C; Harripersaud K; Fuller Lewis C
    AIDS Patient Care STDS; 2015 Aug; 29(8):437-44. PubMed ID: 26217930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?
    García-Ruiz de Morales AG; Martínez-Sanz J; Vivancos-Gallego MJ; Sánchez-Conde M; Vélez-Díaz-Pallarés M; Romero-Hernández B; Vázquez MDG; de Luque CMC; González-Sarria A; Galán JC; Rodríguez FG; Moreno S; Pérez-Elías MJ
    Front Public Health; 2023; 11():1136988. PubMed ID: 37435522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the proportion of patients with hepatitis C treated before and after initiation of an ambulatory pharmacist-led hepatitis C program: A retrospective analysis.
    Ortiz J; Rasch M
    J Am Pharm Assoc (2003); 2023; 63(1):440-446. PubMed ID: 36272941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist-provided rapid HIV testing in two community pharmacies.
    Darin KM; Klepser ME; Klepser DE; Klepser SA; Reeves A; Young M; Scarsi KK
    J Am Pharm Assoc (2003); 2015; 55(1):81-8. PubMed ID: 25415222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies.
    Patel PR; Larson AK; Castel AD; Ganova-Raeva LM; Myers RA; Roup BJ; Farrell KP; Edwards L; Nainan O; Krick JP; Blythe D; Fiore AE; Roche JC
    JAMA; 2006 Oct; 296(16):2005-11. PubMed ID: 17062864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.